Free Trial

Passage Bio (PASG) Earnings Date, Estimates & Call Transcripts

Passage Bio logo
$0.32 +0.02 (+6.31%)
As of 09:54 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Passage Bio Earnings Summary

Passage Bio announced Q1 2025 earnings on May 13, 2025, reporting an EPS of -$0.25, which missed the consensus estimate of -$0.24 by $0.01. With a trailing EPS of -$1.02, Passage Bio's earnings are expected to grow next year, from ($1.03) to ($0.74) per share.

Latest Q1
Earnings Date
May. 13Estimated
Consensus EPS
(May. 13)
-$0.24
Actual EPS
(May. 13)
-$0.25 Missed By -$0.01

Q1 2025 Earnings Resources

Get Passage Bio Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Passage Bio and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

PASG Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Passage Bio Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20251-$0.23-$0.23-$0.23
Q2 20251-$0.22-$0.22-$0.22
Q3 20251-$0.21-$0.21-$0.21
Q4 20251-$0.21-$0.21-$0.21

Passage Bio Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
5/13/2025Q1 2025-$0.24-$0.25 -$0.01-$0.25--
3/4/2025Q4 2024-$0.21-$0.20+$0.01-$0.20--
8/8/2024--$0.31-$0.26+$0.05-$0.26--
5/14/2024Q1 2024-$0.37-$0.30+$0.07-$0.30--
3/4/2024Q4 2023-$0.41-$0.30+$0.11-$0.30--
11/13/2023Q3 2023-$0.46-$0.49 -$0.03-$0.49--
8/7/2023Q2 2023-$0.47-$0.44+$0.03-$0.44--

Passage Bio Earnings - Frequently Asked Questions

Passage Bio (NASDAQ:PASG) last announced its quarterly earning data on Tuesday, May 13, 2025. Learn more on PASG's earnings history.

In the previous quarter, Passage Bio (NASDAQ:PASG) missed the analysts' consensus estimate of ($0.24) by $0.01 with a reported earnings per share (EPS) of ($0.25). Learn more on analysts' earnings estimate vs. PASG's actual earnings.

Passage Bio (NASDAQ:PASG) has a recorded net income of -$102.06 million. PASG has generated -$1.02 earnings per share over the last four quarters.

Passage Bio's earnings are expected to grow from ($1.03) per share to ($0.74) per share in the next year.

More Earnings Resources from MarketBeat



This page (NASDAQ:PASG) was last updated on 5/22/2025 by MarketBeat.com Staff
From Our Partners